Loading stock data…
Pro-Dex, Inc. (PDEX)
$66.41-7.00 (-9.54%)
Market ClosedLast close Sep 8
Pro-Dex, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Pro-Dex, Inc. in the Healthcare sector is trading at $66.41 with a market capitalization of $213M. Wall Street consensus targets $70.00 (1 analysts), implying a +5.4% move over the next 12 months. The stock is currently near its 52-week high of $77.00, remaining 28.3% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +5.4% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $19.95M↑ | $18.66M↑ | $18.53M↑ | $17.49M↑ | $17.41M |
| Gross Profit | $6.13M↑ | $5.74M↑ | $5.37M↑ | $3.49M↓ | $5.80M |
| Operating Income | $3.09M↓ | $3.26M↑ | $3.11M↑ | $1.34M↓ | $3.64M |
| Net Income | $3.94M↑ | $2.19M↓ | $4.68M↑ | $1.20M↓ | $3.27M |
Peer Comparison
JNJUNHPFE
Fundamentals
Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shave...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$212.73M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
16.12
Beta
Defensive asset. Lower volatility than the S&P 500.
0.06
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
26.55%
Volume
Today's trading volume
106,802
Recent News
Dell Afterglow Continues. These Other Stocks Top Buy Points.
Dell Technologies' superb earnings report is still reverberating across the stock market, as the stock climbed to a new high Friday.
Vivos Therapeutics, Inc. (VVOS) Reports Q2 Loss, Lags Revenue Estimates
Vivos Therapeutics (VVOS) delivered earnings and revenue surprises of +26.19% and -5.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Aveanna Healthcare (AVAH) Beats Q2 Earnings and Revenue Estimates
Aveanna (AVAH) delivered earnings and revenue surprises of +29.41% and +3.62%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Pro-Dex Inc (PDEX) Positioned to Strengthen with Zimmer’s mBos Robot Commercialization
Long Cast Advisers, an independent registered investment adviser, released its Q2 2026 investor letter. A copy can be downloaded here. The firm reported strong earnings in the second quarter, with results improving 20%, bringing year-to-date returns to +19%. While performance trailed the Russell 2000 and iShares US MicroCap ETF, it remained well ahead of the […]
Dentsply International (XRAY) Beats Q2 Earnings and Revenue Estimates
Dentsply (XRAY) delivered earnings and revenue surprises of +44.44% and +1.60%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?